Jiangsu Nhwa Pharmaceutical Co Ltd (SZSE:002262) Share Price

Company Profile

Business description
Jiangsu Nhwa Pharmaceutical Co Ltd is a drug manufacturer. The company is engaged in the manufacturing of APIs and dosages. The company markets its pharmaceutical products in four main categories: anesthetic drugs, such as midazolam injection and etomidate fat emulsion injection; psychiatric drugs, including risperidone tablets and related products; neurological drugs, such as gabapentin capsules; and bulk pharmaceuticals, including fenofibrate and miconazole nitrate. In addition, the company is also involved in the pharmaceuticals trading business.
Contact
No. 31, Longhu West Road
Enhua Technology Building
Economic and Technological Development Zone
Xuzhou221009
CHN
T: +86 51687767115
https://www.nhwa-group.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
5,923

Recommended

Shares have dropped 20% in the previous year due to concerns about tariffs.

Esther Holloway | 27 October 2025

Higher gold prices are making a difference to the bottom line but investors overly optimistic.

Jon Mills, CFA | 27 October 2025

We see faster cloud growth and improved longer-term profitability for Alphabet.

Malik Ahmed Khan, CFA | 25 October 2025

Index	Last price	Change	% Change
All Ordinaries	9,295.80	26.20	-0.28%
CAC 40	8,221.11	18.07	-0.22%
DAX 40	24,279.05	29.73	-0.12%
Dow JONES (US)	47,544.59	337.47	0.71%
FTSE 100	9,692.32	38.50	0.40%
HKSE	26,346.14	87.56	-0.33%
NASDAQ	23,637.46	432.59	1.86%
Nikkei 225	50,219.18	293.14	-0.58%
NZX 50 Index	13,402.66	11.07	0.08%
S&P 500	6,875.16	0.00	0.00%
S&P/ASX 200	9,012.50	16.30	-0.18%
SSE Composite Index	3,988.22	8.72	-0.22%